{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:55:05Z","timestamp":1772992505338,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CDMRP BCRP, Breakthrough Level 1"],"award-info":[{"award-number":["CDMRP BCRP, Breakthrough Level 1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10549-016-3816-x","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T06:50:54Z","timestamp":1462344654000},"page":"217-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1"],"prefix":"10.1007","volume":"157","author":[{"given":"Cecilia L.","family":"Speyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdy A.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Hachem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam A.","family":"Bukhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waris S.","family":"Jafry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa M.","family":"Khansa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"issue":"2","key":"3816_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2012","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2012) Global cancer statistics. CA Cancer J Clin 65(2):87\u2013108. doi: 10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"3816_CR2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21332","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin. doi: 10.3322\/caac.21332","journal-title":"CA Cancer J Clin"},{"key":"3816_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1548-5315(11)70394-1","volume":"7","author":"DW Cleere","year":"2010","unstructured":"Cleere DW (2010) Triple-negative breast cancer: a clinical update. Commun Oncol 7:203\u2013211","journal-title":"Commun Oncol"},{"issue":"20","key":"3816_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938\u20131948. doi: 10.1056\/NEJMra1001389","journal-title":"N Engl J Med"},{"issue":"17","key":"3816_CR5","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1158\/1078-0432.CCR-14-3122","volume":"21","author":"SA Narod","year":"2015","unstructured":"Narod SA, Dent RA, Foulkes WD (2015) CCR 20th anniversary commentary: triple-negative breast cancer in 2015-still in the ballpark. Clin Cancer Res 21(17):3813\u20133814. doi: 10.1158\/1078-0432.CCR-14-3122","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3816_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-010-1293-1","volume":"125","author":"SK Pal","year":"2011","unstructured":"Pal SK, Childs BH, Pegram M (2011) Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 125(3):627\u2013636. doi: 10.1007\/s10549-010-1293-1","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3816_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-011-1624-x","volume":"132","author":"CL Speyer","year":"2012","unstructured":"Speyer CL, Smith JS, Banda M, DeVries JA, Mekani T, Gorski DH (2012) Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat 132(2):565\u2013573. doi: 10.1007\/s10549-011-1624-x","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3816_CR8","doi-asserted-by":"publisher","first-page":"e81126","DOI":"10.1371\/journal.pone.0081126","volume":"9","author":"M Banda","year":"2014","unstructured":"Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH (2014) Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer. PLoS One 9(1):e81126. doi: 10.1371\/journal.pone.0081126","journal-title":"PLoS One"},{"issue":"3","key":"3816_CR9","doi-asserted-by":"publisher","first-page":"e88830","DOI":"10.1371\/journal.pone.0088830","volume":"9","author":"CL Speyer","year":"2014","unstructured":"Speyer CL, Hachem AH, Assi AA, Johnson JS, DeVries JA, Gorski DH (2014) Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer. PLoS One 9(3):e88830. doi: 10.1371\/journal.pone.0088830","journal-title":"PLoS One"},{"issue":"1","key":"3816_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10549-015-3365-8","volume":"151","author":"JL Teh","year":"2015","unstructured":"Teh JL, Shah R, La Cava S, Dolfi SC, Mehta MS, Kongara S, Price S, Ganesan S, Reuhl KR, Hirshfield KM, Karantza V, Chen S (2015) Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells. Breast Cancer Res Treat 151(1):57\u201373. doi: 10.1007\/s10549-015-3365-8","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3816_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tvjl.2005.11.007","volume":"173","author":"SR Platt","year":"2007","unstructured":"Platt SR (2007) The role of glutamate in central nervous system health and disease\u2014a review. Vet J 173(2):278\u2013286. doi: 10.1016\/j.tvjl.2005.11.007","journal-title":"Vet J"},{"issue":"1","key":"3816_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","volume":"17","author":"MC Bellingham","year":"2011","unstructured":"Bellingham MC (2011) A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther 17(1):4\u201331. doi: 10.1111\/j.1755-5949.2009.00116.x","journal-title":"CNS Neurosci Ther"},{"issue":"1\u20132","key":"3816_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.brainres.2004.07.074","volume":"1024","author":"T Endoh","year":"2004","unstructured":"Endoh T (2004) Characterization of modulatory effects of postsynaptic metabotropic glutamate receptors on calcium currents in rat nucleus tractus solitarius. Brain Res 1024(1\u20132):212\u2013224. doi: 10.1016\/j.brainres.2004.07.074","journal-title":"Brain Res"},{"issue":"9030","key":"3816_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(96)03181-9","volume":"348","author":"J Wokke","year":"1996","unstructured":"Wokke J (1996) Riluzole. Lancet 348(9030):795\u2013799. doi: 10.1016\/S0140-6736(96)03181-9","journal-title":"Lancet"},{"issue":"1","key":"3816_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ng1148","volume":"34","author":"PM Pollock","year":"2003","unstructured":"Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, Koganti A, Zhu H, Robbins C, Makalowska I, Shin SS, Marin Y, Roberts KG, Yudt LM, Chen A, Cheng J, Incao A, Pinkett HW, Graham CL, Dunn K, Crespo-Carbone SM, Mackason KR, Ryan KB, Sinsimer D, Goydos J, Reuhl KR, Eckhaus M, Meltzer PS, Pavan WJ, Trent JM, Chen S (2003) Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 34(1):108\u2013112. doi: 10.1038\/ng1148","journal-title":"Nat Genet"},{"issue":"5","key":"3816_CR16","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-06-3665","volume":"67","author":"J Namkoong","year":"2007","unstructured":"Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, Goydos JS, Chen S (2007) Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 67(5):2298\u20132305. doi: 10.1158\/0008-5472.CAN-06-3665","journal-title":"Cancer Res"},{"issue":"9","key":"3816_CR17","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1038\/jid.2010.126","volume":"130","author":"MN Le","year":"2010","unstructured":"Le MN, Chan JL, Rosenberg SA, Nabatian AS, Merrigan KT, Cohen-Solal KA, Goydos JS (2010) The glutamate release inhibitor riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol 130(9):2240\u20132249. doi: 10.1038\/jid.2010.126","journal-title":"J Invest Dermatol"},{"issue":"22","key":"3816_CR18","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1158\/1078-0432.CCR-11-0098","volume":"17","author":"HJ Lee","year":"2011","unstructured":"Lee HJ, Wall BA, Wangari-Talbot J, Shin SS, Rosenberg S, Chan JL, Namkoong J, Goydos JS, Chen S (2011) Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies. Clin Cancer Res 17(22):7080\u20137092. doi: 10.1158\/1078-0432.CCR-11-0098","journal-title":"Clin Cancer Res"},{"key":"3816_CR19","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1158\/0008-5472.CAN-13-1531","volume":"74","author":"YY Wen","year":"2014","unstructured":"Wen YY, Li J, Koo J, Shin SS, Lin Y, Jeong BS, Mehnert JM, Chen S, Cohen-Solal K, Goydos JS (2014) Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression. Cancer Res 74:2499\u20132509. doi: 10.1158\/0008-5472.CAN-13-1531","journal-title":"Cancer Res"},{"issue":"1","key":"3816_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tranon.2014.11.001","volume":"8","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg SA, Niglio SA, Salehomoum N, Chan JL, Jeong BS, Wen Y, Li J, Fukui J, Chen S, Shin SS, Goydos JS (2015) Targeting glutamatergic signaling and the PI3 kinase pathway to halt melanoma progression. Transl Oncol 8(1):1\u20139. doi: 10.1016\/j.tranon.2014.11.001","journal-title":"Transl Oncol"},{"issue":"2","key":"3816_CR21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3565(24)36856-9","volume":"282","author":"JH Song","year":"1997","unstructured":"Song JH, Huang CS, Nagata K, Yeh JZ, Narahashi T (1997) Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 282(2):707\u2013714","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"3816_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/nbdi.2000.0297","volume":"7","author":"KM Noh","year":"2000","unstructured":"Noh KM, Hwang JY, Shin HC, Koh JY (2000) A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol Dis 7(4):375\u2013383. doi: 10.1006\/nbdi.2000.0297","journal-title":"Neurobiol Dis"},{"issue":"1\u20133","key":"3816_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2013.04.048","volume":"713","author":"JS Choi","year":"2013","unstructured":"Choi JS, Ryu JH, Zuo Z, Yang SM, Chang HW, Do SH (2013) Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition. Eur J Pharmacol 713(1\u20133):39\u201343. doi: 10.1016\/j.ejphar.2013.04.048","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"3816_CR24","doi-asserted-by":"publisher","first-page":"e69851","DOI":"10.1371\/journal.pone.0069851","volume":"8","author":"MS Mehta","year":"2013","unstructured":"Mehta MS, Dolfi SC, Bronfenbrener R, Bilal E, Chen C, Moore D, Lin Y, Rahim H, Aisner S, Kersellius RD, Teh J, Chen S, Toppmeyer DL, Medina DJ, Ganesan S, Vazquez A, Hirshfield KM (2013) Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS ONE 8(7):e69851. doi: 10.1371\/journal.pone.0069851","journal-title":"PLoS ONE"},{"issue":"5","key":"3816_CR25","first-page":"978","volume":"57","author":"CI Sartor","year":"1997","unstructured":"Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP (1997) Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 57(5):978\u2013987","journal-title":"Cancer Res"},{"issue":"4","key":"3816_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/bcr73","volume":"2","author":"SL Tannheimer","year":"2000","unstructured":"Tannheimer SL, Rehemtulla A, Ethier SP (2000) Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res 2(4):311\u2013320","journal-title":"Breast Cancer Res"},{"issue":"6","key":"3816_CR27","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52(6):1399\u20131405","journal-title":"Cancer Res"},{"issue":"7","key":"3816_CR28","doi-asserted-by":"publisher","first-page":"e6146","DOI":"10.1371\/journal.pone.0006146","volume":"4","author":"J Kao","year":"2009","unstructured":"Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4(7):e6146. doi: 10.1371\/journal.pone.0006146","journal-title":"PLoS One"},{"issue":"7","key":"3816_CR29","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-10-1276","volume":"17","author":"AJ Khan","year":"2011","unstructured":"Khan AJ, Wall BA, Ahlawat S, Green C, Schiff D, Mehnert JM, Goydos JS, Chen S, Haffty BG (2011) Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo. Clin Cancer Res 17(7):1807\u20131814. doi: 10.1158\/1078-0432.CCR-10-1276","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3816_CR30","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/1523-1747.ep12340194","volume":"106","author":"S Chen","year":"1996","unstructured":"Chen S, Zhu H, Wetzel WJ, Philbert MA (1996) Spontaneous melanocytosis in transgenic mice. J Invest Dermatol 106(5):1145\u20131151","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3816_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1034\/j.1600-0749.2000.130307.x","volume":"13","author":"H Zhu","year":"2000","unstructured":"Zhu H, Reuhl K, Botha R, Ryan K, Wei J, Chen S (2000) Development of early melanocytic lesions in transgenic mice predisposed to melanoma. Pigment Cell Res 13(3):158\u2013164","journal-title":"Pigment Cell Res"},{"issue":"3","key":"3816_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1523-1747.1998.00133.x","volume":"110","author":"H Zhu","year":"1998","unstructured":"Zhu H, Reuhl K, Zhang X, Botha R, Ryan K, Wei J, Chen S (1998) Development of heritable melanoma in transgenic mice. J Invest Dermatol 110(3):247\u2013252. doi: 10.1046\/j.1523-1747.1998.00133.x","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3816_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1755-148X.2008.00452.x","volume":"21","author":"SS Shin","year":"2008","unstructured":"Shin SS, Namkoong J, Wall BA, Gleason R, Lee HJ, Chen S (2008) Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res 21(3):368\u2013378. doi: 10.1111\/j.1755-148X.2008.00452.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"3816_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-014-0277-x","volume":"14","author":"M Nelson","year":"2015","unstructured":"Nelson M, Yang M, Dowle AA, Thomas JR, Brackenbury WJ (2015) The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis. Mol Cancer 14:13. doi: 10.1186\/s12943-014-0277-x","journal-title":"Mol Cancer"},{"key":"3816_CR35","doi-asserted-by":"publisher","unstructured":"Nelson M, Yang M, Millican-Slater R, Brackenbury WJ (2015) Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo. Oncotarget 6(32):32914\u201332929. doi: 10.18632\/oncotarget.5441","DOI":"10.18632\/oncotarget.5441"},{"issue":"2\u20133","key":"3816_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0014-2999(93)90147-A","volume":"235","author":"MW Debono","year":"1993","unstructured":"Debono MW, Le Guern J, Canton T, Doble A, Pradier L (1993) Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol 235(2\u20133):283\u2013289","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3816_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/PL00005241","volume":"358","author":"BD Kretschmer","year":"1998","unstructured":"Kretschmer BD, Kratzer U, Schmidt WJ (1998) Riluzole, a glutamate release inhibitor, and motor behavior. Naunyn Schmiedebergs Arch Pharmacol 358(2):181\u2013190","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"3816_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0006-8993(00)02430-6","volume":"871","author":"RD Azbill","year":"2000","unstructured":"Azbill RD, Mu X, Springer JE (2000) Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res 871(2):175\u2013180","journal-title":"Brain Res"},{"issue":"5","key":"3816_CR39","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.23-05-01688.2003","volume":"23","author":"J Dunlop","year":"2003","unstructured":"Dunlop J, Beal McIlvain H, She Y, Howland DS (2003) Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J Neurosci 23(5):1688\u20131696","journal-title":"J Neurosci"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3816-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3816-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:12:16Z","timestamp":1748909536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3816-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3816"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3816-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,4]]},"assertion":[{"value":"19 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}